These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33085540)

  • 1. The impact of intestinal microbiota on weight loss in Parkinson's disease patients: a pilot study.
    Del Chierico F; Grassini P; Quagliariello A; Torti M; Russo A; Reddel S; Stocchi F
    Future Microbiol; 2020 Sep; 15():1393-1404. PubMed ID: 33085540
    [No Abstract]   [Full Text] [Related]  

  • 2. Dysbiosis of gut microbiota in a selected population of Parkinson's patients.
    Pietrucci D; Cerroni R; Unida V; Farcomeni A; Pierantozzi M; Mercuri NB; Biocca S; Stefani A; Desideri A
    Parkinsonism Relat Disord; 2019 Aug; 65():124-130. PubMed ID: 31174953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Pilot Microbiota Study in Parkinson's Disease Patients versus Control Subjects, and Effects of FTY720 and FTY720-Mitoxy Therapies in Parkinsonian and Multiple System Atrophy Mouse Models.
    Vidal-Martinez G; Chin B; Camarillo C; Herrera GV; Yang B; Sarosiek I; Perez RG
    J Parkinsons Dis; 2020; 10(1):185-192. PubMed ID: 31561385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered gut microbiota in Parkinson's disease patients/healthy spouses and its association with clinical features.
    Zhang F; Yue L; Fang X; Wang G; Li C; Sun X; Jia X; Yang J; Song J; Zhang Y; Guo C; Ma G; Sang M; Chen F; Wang P
    Parkinsonism Relat Disord; 2020 Dec; 81():84-88. PubMed ID: 33099131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota in patients with Parkinson's disease in southern China.
    Lin A; Zheng W; He Y; Tang W; Wei X; He R; Huang W; Su Y; Huang Y; Zhou H; Xie H
    Parkinsonism Relat Disord; 2018 Aug; 53():82-88. PubMed ID: 29776865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural changes of gut microbiota in Parkinson's disease and its correlation with clinical features.
    Li W; Wu X; Hu X; Wang T; Liang S; Duan Y; Jin F; Qin B
    Sci China Life Sci; 2017 Nov; 60(11):1223-1233. PubMed ID: 28536926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder.
    Heintz-Buschart A; Pandey U; Wicke T; Sixel-Döring F; Janzen A; Sittig-Wiegand E; Trenkwalder C; Oertel WH; Mollenhauer B; Wilmes P
    Mov Disord; 2018 Jan; 33(1):88-98. PubMed ID: 28843021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls.
    Unger MM; Spiegel J; Dillmann KU; Grundmann D; Philippeit H; Bürmann J; Faßbender K; Schwiertz A; Schäfer KH
    Parkinsonism Relat Disord; 2016 Nov; 32():66-72. PubMed ID: 27591074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. More than constipation - bowel symptoms in Parkinson's disease and their connection to gut microbiota.
    Mertsalmi TH; Aho VTE; Pereira PAB; Paulin L; Pekkonen E; Auvinen P; Scheperjans F
    Eur J Neurol; 2017 Nov; 24(11):1375-1383. PubMed ID: 28891262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration of the fecal microbiota in North-Eastern Han Chinese population with sporadic Parkinson's disease.
    Li F; Wang P; Chen Z; Sui X; Xie X; Zhang J
    Neurosci Lett; 2019 Aug; 707():134297. PubMed ID: 31200089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The oral microbiome of early stage Parkinson's disease and its relationship with functional measures of motor and non-motor function.
    Mihaila D; Donegan J; Barns S; LaRocca D; Du Q; Zheng D; Vidal M; Neville C; Uhlig R; Middleton FA
    PLoS One; 2019; 14(6):e0218252. PubMed ID: 31247001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered gut microbiota in patients with idiopathic Parkinson's disease: an age-sex matched case-control study.
    Babacan Yildiz G; Kayacan ZC; Karacan I; Sumbul B; Elibol B; Gelisin O; Akgul O
    Acta Neurol Belg; 2023 Jun; 123(3):999-1009. PubMed ID: 36719617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson's disease patients.
    Bedarf JR; Hildebrand F; Coelho LP; Sunagawa S; Bahram M; Goeser F; Bork P; Wüllner U
    Genome Med; 2017 Apr; 9(1):39. PubMed ID: 28449715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson's disease.
    Lin CH; Chen CC; Chiang HL; Liou JM; Chang CM; Lu TP; Chuang EY; Tai YC; Cheng C; Lin HY; Wu MS
    J Neuroinflammation; 2019 Jun; 16(1):129. PubMed ID: 31248424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of Gut Microbiota in Patients with Parkinson's Disease.
    Petrov VA; Saltykova IV; Zhukova IA; Alifirova VM; Zhukova NG; Dorofeeva YB; Tyakht AV; Kovarsky BA; Alekseev DG; Kostryukova ES; Mironova YS; Izhboldina OP; Nikitina MA; Perevozchikova TV; Fait EA; Babenko VV; Vakhitova MT; Govorun VM; Sazonov AE
    Bull Exp Biol Med; 2017 Apr; 162(6):734-737. PubMed ID: 28429209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral, Nasal, and Gut Microbiota in Parkinson's Disease.
    Li Z; Lu G; Luo E; Wu B; Li Z; Guo J; Xia Z; Zheng C; Su Q; Zeng Y; Chan WY; Su X; Qiu X; Zheng X; Cai Q; Xu Y; Chen Y; Fan Y; Chen W; Yu Z; Chen X; Zheng C; Wang M; Poon WS; Luo X
    Neuroscience; 2022 Jan; 480():65-78. PubMed ID: 34695538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut bacterial composition in a mouse model of Parkinson's disease.
    Perez-Pardo P; Dodiya HB; Engen PA; Naqib A; Forsyth CB; Green SJ; Garssen J; Keshavarzian A; Kraneveld AD
    Benef Microbes; 2018 Sep; 9(5):799-814. PubMed ID: 30099890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkinson's disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions.
    Baldini F; Hertel J; Sandt E; Thinnes CC; Neuberger-Castillo L; Pavelka L; Betsou F; Krüger R; Thiele I;
    BMC Biol; 2020 Jun; 18(1):62. PubMed ID: 32517799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Phenotypes of Parkinson's Disease Associate with Distinct Gut Microbiota and Metabolome Enterotypes.
    Vascellari S; Melis M; Palmas V; Pisanu S; Serra A; Perra D; Santoru ML; Oppo V; Cusano R; Uva P; Atzori L; Morelli M; Cossu G; Manzin A
    Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33499229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in Gut Microbiome after Bariatric Surgery Versus Medical Weight Loss in a Pilot Randomized Trial.
    Lee CJ; Florea L; Sears CL; Maruthur N; Potter JJ; Schweitzer M; Magnuson T; Clark JM
    Obes Surg; 2019 Oct; 29(10):3239-3245. PubMed ID: 31256356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.